Carlsmed, Inc. (CARL)
NMS · Healthcare · Health Information Services
$14.73
-0.20%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$402.2M
Shares Outstanding
27.3M
P/S (TTM)
6.4x
Exchange
NMS
Currency
USD
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 13.1M | 15.2M | 16.1M | 18.9M |
| Gross Profit | 9.9M | 11.6M | 12.4M | 14.5M |
| Operating Income | (9.0M) | (9.3M) | (9.3M) | (11.0M) |
| Net Income | (8.5M) | (8.6M) | (8.7M) | (10.5M) |
| Diluted EPS | $-0.40 | $-0.32 | $-0.32 | $-0.39 |
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 13.8M | 27.2M | 50.5M |
| Gross Profit | 9.9M | 20.0M | 38.0M |
| Operating Income | (18.6M) | (24.1M) | (30.6M) |
| Net Income | (18.9M) | (24.3M) | (29.6M) |
| Diluted EPS | $-4.25 | $-6.11 | $-2.12 |